Showing results (161-170 of 573) with videos related to

Sort By:
Pageof 58
Infection Control and Hospital Epidemiology|September 26, 2024
Antibiogram development for Australian residential aged care facilitiesDipti Khatri, Nazanin Falconer, Sonali Coulter, et al.
Jac-Antimicrobial Resistance|November 10, 2021
Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysisWeiping Ling, Luis Furuya-Kanamori, Yukiko Ezure, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 4, 2022
Determinants and outcomes of bloodstream infections related to obesityFelicity Edwards, Kate Glen, Patrick N A Harris, et al.
Critical Care Medicine|May 24, 2014
A new marker of sepsis post burn injury?*Jennifer D Paratz, Jeffrey Lipman, Robert J Boots, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2024
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO TrialMelissa Hardy, Patrick N A Harris, David L Paterson, et al.
Access Microbiology|January 13, 2022
Pneumococcal serotypes causing non-invasive pneumonia in adults from a South Indian tertiary care hospital and the impact of the newer conjugate vaccinesRosemol Varghese, Binesh Lal Yesudhason, Leena Robinson Vimala, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 2025
Large Tuberculous Mass Lesions Involving the Brain: Outcomes and ManagementPrasannakumar Palanikumar, Priyanka Gautam, Harshad Arvind Vanjare, et al.
Indian Journal of Medical Microbiology|February 7, 2018
Dosing strategy based on prevailing aminoglycoside minimum inhibitory concentration in India: Evidence and issuesBalaji Veeraraghavan, Agila Kumari Pragasam, Abi Manesh, et al.
Current Microbiology|October 25, 2025
Evaluating Antibacterial Efficacy of Cefiderocol and Cefepime/Taniborbactam Against OXA-48-Like and NDM-Expressing Enterobacterales: An In-Vitro and In-Silico ApproachMohanraj Gopikrishnan, Sriroopreddy Ramireddy, Yamuna Devi Bakathavatchalam, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2025
A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter sppBalaji Veeraraghavan, Eunjeong Shin, Yamuna Devi Bakthavatchalam, et al.
Pageof 58